Themis Medicare — 360° view

Themis Medicare, a company in the Pharmaceuticals industry, reported revenue of ₹90 crore and net profit of ₹7.06 crore for the September 2026 quarter.

Themis Medicare (NSE: THEMISMED) closed at ₹94.87 on 20 Nov 2026, down 15.7% over the past year. Its market capitalisation is ₹874 crore.

Share price
₹94.87 (20 Nov 2026)
Market cap
₹874 Cr (20 Nov 2026)
Revenue
₹90 Cr (September 2026 quarter)
Net profit
₹7 Cr (September 2026 quarter)
ROCE
2.74% (FY26)
ROE
0.41% (FY26)
Book value
₹46.2 (FY26)
Dividend yield
0.53% (last 12 months to 20 Nov 2026)
52-week high / low
₹140.60 / ₹64.95 (20 Nov 2026)
1-year return
-15.7% (to 20 Nov 2026)
Sector
Healthcare
Industry
Pharmaceuticals
Symbol
NSE: THEMISMED

Incorporated in 1969, Themis Medicare manufactures Formulation and API pharmaceutical products

Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.